Patents by Inventor Itzik Cooper

Itzik Cooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR CHANGING BLOOD BRAIN BARRIER PERMEABILITY
    Publication number: 20240100326
    Abstract: A system and a method for increasing permeability of a brain barrier selected from a blood-brain barrier or a blood-cerebrospinal fluid barrier by controlled application of pulsed electric fields.
    Type: Application
    Filed: November 30, 2023
    Publication date: March 28, 2024
    Inventors: Yael MARDOR, Shirley SHARABI, Itzik COOPER, David LAST, David GUEZ, Dianne DANIELS ELMAKIAS, Yael BRESLER
  • Method for changing blood brain barrier permeability
    Patent number: 11931569
    Abstract: A system and a method for increasing permeability of a brain barrier selected from a blood-brain barrier or a blood-cerebrospinal fluid barrier by controlled application of pulsed electric fields.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: March 19, 2024
    Assignee: TEL HASHOMER MEDICAL RESEARCH, INFRASTRUCTURE & SERVICES LTD.
    Inventors: Yael Mardor, Shirley Sharabi, Itzik Cooper, David Last, David Guez, Dianne Daniels Elmakias, Yael Bresler
  • METHOD FOR CHANGING BLOOD BRAIN BARRIER PERMEABILITY
    Publication number: 20210016084
    Abstract: A system and a method for increasing permeability of a brain barrier selected from a blood-brain barrier or a blood-cerebrospinal fluid barrier by controlled application of pulsed electric fields.
    Type: Application
    Filed: March 12, 2019
    Publication date: January 21, 2021
    Inventors: Yael MARDOR, Shirley SHARABI, Itzik COOPER, David LAST, David Guez, Dianne DANIELS ELMAKIAS, Yael BRESLER
  • BLOOD-BRAIN BARRIER DISRUPTING AGENTS AND USES THEREOF
    Publication number: 20170247429
    Abstract: The present invention relates to blood-brain barrier disrupting agents containing a modified serum albumin comprising serum albumin. The present invention further relates to pharmaceutical compositions comprising said agents and use thereof for the treatment of brain diseases and disorders.
    Type: Application
    Filed: September 16, 2015
    Publication date: August 31, 2017
    Inventors: Itzik Cooper, David Guez, David Last, Yoram Shechter, Matityahu Fridkin, Yael Mardor